AlleyCorp’s Newsletter
Subscribe
Sign in
Home
Archive
About
AlleyCorp Incubation Transcend Therapeutics to be Acquired by Otsuka Pharmaceutical
As many of you know, I’ve spent the better part of the last five years chairing the board of Transcend Therapeutics, a biotech company that we founded…
Apr 7
•
Kevin Ryan
20
Latest
Top
AlleyCorp in Q4 and the 30th Anniversary of Silicon Alley
Highlighting our latest portfolio milestones and the celebration of 30+ years of Silicon Alley
Jan 13
•
Kevin Ryan
5
AlleyCorp in Q3: Two New Unicorns in the Portfolio
ShopMy and Thyme Care reach acclaimed unicorn status, as Radical AI raises the 3rd largest seed round in NYC Tech history.
Oct 22, 2025
•
Kevin Ryan
6
1
AlleyCorp in Q2: Rogo Takes Flight & NYC Mayoral Race
Updates on AI's impact on Wall Street, and a conversation with NYC Democratic Mayoral Nominee Zohran Mamdani
Jul 15, 2025
•
Kevin Ryan
3
1
AlleyCorp in Q1: Transcend’s Progress in Psychiatric Medicine
AlleyCorp portfolio companies raised nearly half a billion dollars in funding this quarter, but the most significant development was the compelling…
Apr 11, 2025
•
Kevin Ryan
2
Introducing Alexi Nazem as AlleyCorp's General Partner leading Healthcare
Today, we are excited to welcome Alexi Nazem as AlleyCorp’s newest General Partner, leading our healthcare portfolio.
Jan 27, 2025
•
Kevin Ryan
5
AlleyCorp in Q4 and What's Ahead for 2025
As we close out 2024, we have many exciting things in store for the year ahead including the opening of our new building and a new Deep Tech summit.
Jan 14, 2025
•
Kevin Ryan
4
1
AlleyCorp in Q3: The AI Hype Continues
Our positions in AI, along with new investments, initiatives and more from AlleyCorp.
Oct 10, 2024
•
Kevin Ryan
5
See all
AlleyCorp’s Newsletter
News and Updates from AlleyCorp
Subscribe
AlleyCorp’s Newsletter
Subscribe
About
Archive
Sitemap
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
